Investingnews

RAD 202 receives approval to start Phase 1 therapeutic trial

6 hours ago

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Completion of Tranche 1 of the Placement

20 minutes ago

5 Best-performing Canadian Nickel Stocks of 2024

4 hours ago

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

4 hours ago

Completion of Tranche 1 of the Placement

20 minutes ago

A tale of two Syrians: One finally made it back, another is too fearful to return

1 hour ago

Japan’s government ‘alarmed’ by recent forex moves, top officials say

1 hour ago

Tokyo inflation likely accelerated on suspended energy subsidies: Reuters poll

1 hour ago

Asia FX fragile with dollar upbeat ahead of PCE data; yen hits 5-mth low

1 hour ago